Kirschner v. JP Morgan Chase Bank, N.A.

CourtDistrict Court, S.D. New York
DecidedSeptember 30, 2021
Docket1:17-cv-06334
StatusUnknown

This text of Kirschner v. JP Morgan Chase Bank, N.A. (Kirschner v. JP Morgan Chase Bank, N.A.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Kirschner v. JP Morgan Chase Bank, N.A., (S.D.N.Y. 2021).

Opinion

UNITED STATES DISTRICT COURT SOUTHERN DISTRICT OF NEW YORK

MARC S. KIRSCHNER, solely in his capacity as Trustee of THE MILLENNIUM LENDER CLAIM TRUST, ORDER

Plaintiff, 17 Civ. 6334 (PGG)

- against -

JPMORGAN CHASE BANK, N.A.; JPMORGAN SECURITIES LLC; CITIGROUP GLOBAL MARKETS INC.; CITIBANK, N.A.; BMO CAPITAL MARKETS CORP.; BANK OF MONTREAL; SUNTRUST ROBINSON HUMPHREY, INC.; and SUNTRUST BANK,

Defendants.

PAUL G. GARDEPHE, U.S.D.J.: Plaintiff Marc S. Kirschner – in his capacity as trustee of the Millennium Lender Claim Trust (the “Trust”) – brings this action against J.P. Morgan Chase Bank, N.A. (“Chase”), J.P. Morgan Securities LLC (“JPM Securities,” with Chase, “JP Morgan”), Citibank, N.A. (“Citibank”), Citigroup Global Markets, Inc. (“CitiGlobal,” with Citibank “Citi”), Bank of Montreal, BMO Capital Markets Corp. (together “BMO”), SunTrust Bank, and SunTrust Robinson Humphrey, Inc. (together “SunTrust”) (collectively, “Defendants”). The Complaint alleges violations of various state securities laws; negligent misrepresentation; breach of fiduciary duty; breach of contract; and breach of the implied covenant of good faith and fair dealing. (Cmplt. (Dkt. No. 1-1)) Plaintiff’s claims arise out of a $1.775 billion syndicated loan transaction1 that closed on April 16, 2014 (the “2014 Transaction” or “2014 Credit Agreement”). (Id. ¶¶ 1, 96) In the 2014 Transaction, Defendants sold to the Trust’s beneficiaries – approximately seventy institutional investor groups, comprised of approximately 400 mutual funds, hedge funds, and

other institutional investors (the “Investors”) – debt obligations of Millennium Laboratories LLC (“Millennium”). (Id. ¶¶ 1, 94-95) In November 2015 – nineteen months after the 2014 Transaction closed – Millennium filed a bankruptcy petition. (Id. ¶ 3) The bankruptcy plan issued by the Bankruptcy Court created the Trust and authorized the Trust to pursue the Investors’ claims against Defendants. (Id. ¶ 8) The Complaint alleges that “Defendants misrepresented or omitted . . . material facts in the offering materials they provided and communications they made to Investors concerning the legality of [Millennium’s] sales, marketing, and billing practices,” as well as “the known risks posed by a pending government investigation into the illegality of such practices.”

(Id. ¶ 1) In a May 22, 2020 opinion (the “May 22, 2020 Opinion”), this Court granted Defendants’ motion to dismiss under Fed. R. Civ. P. 12(b)(6), but gave Plaintiff leave to amend. See generally Kirschner v. JP Morgan Chase Bank, N.A., No. 17 Civ. 6334 (PGG), 2020 WL 2614765 (S.D.N.Y. May 22, 2020). On July 31, 2020, Plaintiff moved for leave to file an amended complaint. (Mot.

1 “A syndicated loan is a commercial credit provided by a group of lenders,” and “is structured, arranged, and administered by one or several commercial or investment banks, known as arrangers.” S&P Global Market Intelligence, Syndicated Loans: The Market and the Mechanics 1 (2017), https://www.lcdcomps.com/d/pdf/LCD%20Loan%20Primer.pdf. (Dkt. No. 132)) The Proposed Amended Complaint (“PAC”) asserts common law fraud claims against JP Morgan and Citi, and aiding and abetting fraud, conspiracy to commit fraud, and negligent misrepresentation claims against all Defendants. (See generally PAC (Dkt. No. 134- 1))

On August 12, 2020, this Court referred Plaintiff’s motion to Magistrate Judge Sarah L. Cave for a Report and Recommendation (“R&R”). (Dkt. No. 148) On December 1, 2020, Judge Cave issued a forty-two page R&R recommending “that Plaintiff’s Motion be denied on grounds of futility.” (R&R (Dkt. No. 169) at 2)2 On January 15, 2021, Plaintiff filed objections to the R&R. (Dkt. No. 172) This Court will adopt the R&R as set forth below. BACKGROUND I. FACTS3 Plaintiff is the trustee of the Millennium Lender Claim Trust. (PAC (Dkt. No. 134-1) ¶¶ 23, 39; id. at 1) Millennium was headquartered in San Diego and provided laboratory-

based diagnostic testing of urine samples for physicians. (Id. ¶ 45) Defendants are national banking associations, a bank chartered under the Bank Act of Canada, a bank chartered under Georgia law, and registered broker-dealers and investment advisors. (Id. ¶¶ 24-32) In April 2011, “a competitor [of Millennium], Ameritox, filed a civil action against Millennium in a federal court in Florida (the ‘Ameritox Litigation’),” alleging violations

2 All references to page numbers in this Order are as reflected in this District’s Electronic Case Files (“ECF”) system. 3 The Court’s factual statement is drawn from the PAC. The well-pleaded facts alleged in the PAC are presumed true for purposes of resolving Plaintiff’s motion for leave to file an amended complaint. See Kassner v. 2nd Ave. Delicatessen, Inc., 496 F.3d 229, 237 (2d Cir. 2007). of the Anti-Kickback statute and the Stark Law. (Id. ¶ 61) In March 2012, the U.S. Department of Justice (“DOJ”) began investigating Millennium for federal healthcare law violations. (Id. at ¶¶ 1-2, 73-74) That same month, Chase, JPM Securities, SunTrust, SunTrust Robinson Humphrey, Bank of Montreal, and “a handful of others” entered into a credit agreement with

Millennium in which they provided the company with a $310 million term loan facility and a $20 million revolving credit facility (the “2012 Credit Agreement”). (Id. ¶72) Defendants monitored the DOJ’s investigation of Millennium and began “exploring with the Insiders ways to sell [Millennium] to a third-party in a mergers and acquisitions transaction and/or to refinance the 2012 Credit [Agreement] with other lenders or through an initial public offering [(‘IPO’)] of Millennium stock” so as to escape their “term loan exposure to Millennium.” (Id. ¶¶ 81, 90; see also id. ¶¶ 84-85; see also id. ¶ 2 (defining “Insiders” as Millennium’s controlling equity, debenture and warrant owners – the founder, president, general counsel, and certain associates from a private equity firm)) In other words, Defendants were working with Millennium on an exit strategy. (Id. ¶¶ 3-6)

“By the end of February 2014, however, the only financing option left on the table was a ‘maximum leverage’ institutional financing” – totaling $1.775 billion – that would “replace[] by allocations and assignments” the banks’ loans with the new Investors’ loans. (Id. ¶ 86 (original alteration marks omitted)) This institutional financing would also provide Millennium’s Insiders with dividends, options, and bonuses “just shy of $1.27 billion.” (Id. ¶ 90 (emphasis omitted); see also id. ¶¶ 6, 16; id. ¶ 17 (“Millennium itself received nothing of value in the 2014 Transaction.”)) In a March 16, 2014 commitment letter (the “2014 Commitment Letter”), JP Morgan, CitiGlobal, SunTrust, and BMO agreed that they would fund the $1.775 billion financing through a term loan as “Initial Lenders,” and “all four of the Defendant broker-dealers were named as ‘Arrangers’ of the syndication effort.” “JPM Securities and CitiGlobal were made ‘Lead Arrangers’ and ‘Joint Bookrunners.’” (Id. ¶¶ 86, 88) The syndicated loan transaction was effectuated on April 16, 2014 (the “2014

Credit Agreement”) after Chase made the initial term loan of $1.775 billion to Millennium, which triggered the commitments of the Investors to purchase the entire amount from Chase through the assigned allocations. (Id. ¶ 15) On June 16, 2014, a jury in the Ameritox case returned a verdict in favor of Ameritox, finding that Millennium had violated both the Anti-Kickback statute and the Stark Law. (Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Port Dock & Stone Corp. v. Oldcastle Northeast, Inc.
507 F.3d 117 (Second Circuit, 2007)
Foman v. Davis
371 U.S. 178 (Supreme Court, 1962)
Reves v. Ernst & Young
494 U.S. 56 (Supreme Court, 1990)
Bell Atlantic Corp. v. Twombly
550 U.S. 544 (Supreme Court, 2007)
Ashcroft v. Iqbal
556 U.S. 662 (Supreme Court, 2009)
Ruotolo v. City of New York
514 F.3d 184 (Second Circuit, 2008)
Kirschner v. Bennett
648 F. Supp. 2d 525 (S.D. New York, 2009)
Kassner v. 2nd Avenue Delicatessen Inc.
496 F.3d 229 (Second Circuit, 2007)
Nelson v. Smith
618 F. Supp. 1186 (S.D. New York, 1985)
Ortiz v. Barkley
558 F. Supp. 2d 444 (S.D. New York, 2008)
Kimmell v. Schaefer
675 N.E.2d 450 (New York Court of Appeals, 1996)
JP Morgan Chase Bank v. Winnick
406 F. Supp. 2d 247 (S.D. New York, 2005)
Fraternity Fund Ltd. v. Beacon Hill Asset Management, LLC
479 F. Supp. 2d 349 (S.D. New York, 2007)
Kottler v. Deutsche Bank AG
607 F. Supp. 2d 447 (S.D. New York, 2009)
King County, Wa v. Ikb Deutsche Industriebank Ag
751 F. Supp. 2d 652 (S.D. New York, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
Kirschner v. JP Morgan Chase Bank, N.A., Counsel Stack Legal Research, https://law.counselstack.com/opinion/kirschner-v-jp-morgan-chase-bank-na-nysd-2021.